Rosa A van Amerongen

2PUBLICATIONS
14CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 19, 2025
TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Rosa A van Amerongen, Sander Tuit, Dennis F G Remst

|Jun 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma.

Rosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst

Pageof 1

Frequent Collaborators

2 joint publications

Peter A van Veelen

2 joint publications

Mirjam H M Heemskerk

1 joint publications

Sander Tuit

1 joint publications

Dennis F G Remst